These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 36105050)

  • 1. Dendritic cells modified by tumor associated antigen SMP30 have enhanced antitumor effect against mouse hepatocarcinoma cells in vitro and in vivo.
    Guo J; Zhang Y; Qin Q; Chao N; Huang T; Chen C; Lu X; Huang R; Pan J
    Am J Transl Res; 2022; 14(8):5785-5799. PubMed ID: 36105050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antitumor activity of lentivirus-mediated interleukin -12 gene modified dendritic cells in human lung cancer in vitro.
    Ahmed Ali HA; Di J; Mei W; Zhang YC; Li Y; Du ZW; Zhang GZ
    Asian Pac J Cancer Prev; 2014; 15(2):611-6. PubMed ID: 24568466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GP96 and SMP30 Protein Priming of Dendritic Cell Vaccination Induces a More Potent CTL Response against Hepatoma.
    Huang R; Pan J; Zhang Y; Qin Q; Chao N; Huang T; Chen C; Zhao F; Luo G
    J Healthc Eng; 2022; 2022():2518847. PubMed ID: 35070229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of antigen-specific immune responses by dendritic cells transduced with a recombinant lentiviral vector encoding MAGE-A3 gene.
    Lin L; Wei J; Chen Y; Huang A; Li KK; Zhang W
    J Cancer Res Clin Oncol; 2014 Feb; 140(2):281-9. PubMed ID: 24322180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancement of CTLs induced by DCs loaded with ubiquitinated hepatitis B virus core antigen.
    Chen JH; Yu YS; Chen XH; Liu HH; Zang GQ; Tang ZH
    World J Gastroenterol; 2012 Mar; 18(12):1319-27. PubMed ID: 22493545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polyethyleneimine modification of aluminum hydroxide nanoparticle enhances antigen transportation and cross-presentation of dendritic cells.
    Dong H; Wen ZF; Chen L; Zhou N; Liu H; Dong S; Hu HM; Mou Y
    Int J Nanomedicine; 2018; 13():3353-3365. PubMed ID: 29922056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced induction of anti-tumor CTLs in vitro by a lentivirus-transduced dendritic cell vaccine expressing secondary lymphoid tissue chemokine and mucin 1.
    Wang B; Zhu Y; Zhang JJ; Chen Z; Liang WB; Xu ZK
    Asian Pac J Cancer Prev; 2011; 12(11):2811-7. PubMed ID: 22393946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dendritic cells transduced with tumor-associated antigen gene elicit potent therapeutic antitumor immunity: comparison with immunodominant peptide-pulsed DCs.
    Nakamura M; Iwahashi M; Nakamori M; Ueda K; Ojima T; Naka T; Ishida K; Yamaue H
    Oncology; 2005; 68(2-3):163-70. PubMed ID: 16006753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generation of cytotoxic T cell against HBcAg using retrovirally transduced dendritic cells.
    Ding CL; Yao K; Zhang TT; Zhou F; Xu L; Xu JY
    World J Gastroenterol; 2003 Jul; 9(7):1512-5. PubMed ID: 12854153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunization with lentiviral vector-transduced dendritic cells induces strong and long-lasting T cell responses and therapeutic immunity.
    He Y; Zhang J; Mi Z; Robbins P; Falo LD
    J Immunol; 2005 Mar; 174(6):3808-17. PubMed ID: 15749922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of G250-targeted and T-cell-mediated antitumor activity against renal cell carcinoma using a chimeric fusion protein consisting of G250 and granulocyte/monocyte-colony stimulating factor.
    Tso CL; Zisman A; Pantuck A; Calilliw R; Hernandez JM; Paik S; Nguyen D; Gitlitz B; Shintaku PI; de Kernion J; Figlin R; Belldegrun A
    Cancer Res; 2001 Nov; 61(21):7925-33. PubMed ID: 11691814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dendritic cells retrovirally transduced with a model antigen gene are therapeutically effective against established pulmonary metastases.
    Specht JM; Wang G; Do MT; Lam JS; Royal RE; Reeves ME; Rosenberg SA; Hwu P
    J Exp Med; 1997 Oct; 186(8):1213-21. PubMed ID: 9334360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD40ligand-expressing dendritic cells induce regression of hepatocellular carcinoma by activating innate and acquired immunity in vivo.
    Gonzalez-Carmona MA; Lukacs-Kornek V; Timmerman A; Shabani S; Kornek M; Vogt A; Yildiz Y; Sievers E; Schmidt-Wolf IG; Caselmann WH; Sauerbruch T; Schmitz V
    Hepatology; 2008 Jul; 48(1):157-68. PubMed ID: 18537185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dendritic Cells Cross-Present Immunogenic Lentivector-Encoded Antigen from Transduced Cells to Prime Functional T Cell Immunity.
    Hotblack A; Seshadri S; Zhang L; Hamrang-Yousefi S; Chakraverty R; Escors D; Bennett CL
    Mol Ther; 2017 Feb; 25(2):504-511. PubMed ID: 28153097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The boosting effect of co-transduction with cytokine genes on cancer vaccine therapy using genetically modified dendritic cells expressing tumor-associated antigen.
    Ojima T; Iwahashi M; Nakamura M; Matsuda K; Naka T; Nakamori M; Ueda K; Ishida K; Yamaue H
    Int J Oncol; 2006 Apr; 28(4):947-53. PubMed ID: 16525645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Engineering lentiviral vectors for modulation of dendritic cell apoptotic pathways.
    Wang JC; Felizardo TC; Au BC; Fowler DH; Dekaban GA; Medin JA
    Virol J; 2013 Jul; 10():240. PubMed ID: 23870437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NKT and CD8 lymphocytes mediate suppression of hepatocellular carcinoma growth via tumor antigen-pulsed dendritic cells.
    Shibolet O; Alper R; Zlotogarov L; Thalenfeld B; Engelhardt D; Rabbani E; Ilan Y
    Int J Cancer; 2003 Aug; 106(2):236-43. PubMed ID: 12800200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential immune responses mediated by adenovirus- and lentivirus-transduced DCs in a HER-2/neu overexpressing tumor model.
    Felizardo TC; Wang JC; McGray RA; Evelegh C; Spaner DE; Fowler DH; Bramson JL; Medin JA
    Gene Ther; 2011 Oct; 18(10):986-95. PubMed ID: 21490686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recipient dendritic cells modified by RNA interference targeting CD80 and CD86 elicit T cell hyporesponsiveness via enhanced T cell apoptosis.
    Hong J; Gu XD; Xiang JB; Zhang Z; Zang YW; Zhang QH; Qian SG; Chen ZY
    Chin Med J (Engl); 2013; 126(11):2139-44. PubMed ID: 23769573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Immune response of HBsAg gene-modified dendritic cell-based vaccine in HepG2. 2. 15 hepatocellular carcinoma cells].
    Yang JY; Liu WC; Cao DY; Si XM; Teng ZH
    Zhonghua Zhong Liu Za Zhi; 2007 Oct; 29(10):728-32. PubMed ID: 18396682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.